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Abstract
Background: Sarcoptic mange has recently emerged in wild boar in Switzerland, raising the question of the origin
of the infection. The main aim of this study was to assess the extent of exposure of the wild boar populations to
Sarcoptes scabiei in Switzerland, prior to and after the detection of mange cases, to determine whether the mite
has been recently introduced into the populations concerned. We performed a serological survey using a
commercially available ELISA and 1056 archived blood samples of free-ranging wild boar from Switzerland. To
facilitate the interpretation of the obtained data, we additionally estimated seroprevalence in wild boar populations
of four other European countries (1060 samples), both from areas with confirmed clinical cases of mange and from
areas without reported cases in wild boar. Lastly, we revised the evaluation of the commercial ELISA when used
with wild boar sera.
Results: Seropositive reactions were observed for samples from all five countries and from 15 of the 16 study areas.
The obtained apparent seroprevalences ranged from 0.0% (0/82; 95% confidence interval [CI]: 0.0–4.4) to 17.4% (8/
46; 95% CI: 7.8–31.4). Wild boar from study areas with known clinical cases and those ≤60 kg were four times more
likely to be seropositive than wild boar from areas without reported cases and > 60 kg, respectively. Optical density
values did not differ between the two types of study areas among seropositive samples but were significantly
lower among seronegative samples from areas without than from areas with clinical cases. No difference was
observed between the two sampling periods in Switzerland. The revised ELISA specificity was 96.8% (984/1017; 95%
CI: 95.5–97.7) when wild boar from areas without history of mange were considered truly negative.
Conclusions: Seropositivity to S. scabiei is more frequent and occurs over a larger geographic range than expected.
Data suggest that the parasite is endemic within the wild boar populations of Switzerland and other European
countries but that its presence is not necessarily associated with disease occurrence. Extrinsic factors which trigger
disease emergence in infected populations remain to be investigated. The applied ELISA represents a promising
tool for future studies.
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Background
Sarcoptic mange, caused by the burrowing mite Sar-
coptes scabiei, is a highly contagious skin disease which
occurs worldwide and affects a wide range of wild and
domestic mammals as well as humans [1]. Mites are
largely taxon-specific, however, transmissions across
mammalian orders have been reported [2]. The disease
is characterized by varying clinical signs and mortality,
depending on a number of factors such as host species,
season, immune status of the host, and presence of other
diseases or nutritional imbalances [3, 4]. In wildlife, sar-
coptic mange has repeatedly been investigated in various
species developing severe lesions and undergoing high
mortality [5–9]. By contrast, little is known on S. scabiei
infections in wild boar (Sus scrofa), in which disease
signs are relatively mild and mortality seems to be par-
ticularly uncommon [10].
In Switzerland, sarcoptic mange has been present in
carnivores for several decades. It has progressively ex-
panded to the whole Swiss territory in the red fox
(Vulpes vulpes) population, and sporadic cases have also
been observed in other carnivore species [11, 12]. By
contrast, no cases had been recorded in wild ungulates
until 2010, when mange was first diagnosed in wild boar
in two Swiss regions distant from each other [10]. This
disease emergence raised the question as to whether S.
scabiei was recently introduced into the Swiss wild boar
populations or was already present but had remained
undetected. Since scanning surveillance has been shown
to be not sensitive enough to detect mangy animals in
naïve ungulate populations [6] and transmission of S.
scabiei from carnivores to ungulates represents an un-
usual event [13], the possibility that S. scabiei was
already endemic in wild boar in Switzerland deserved to
be more carefully addressed.
Serology documents pathogen exposure independently
of the presence of clinical signs or lesions, which makes
it a useful tool to assess pathogen emergence when ar-
chived blood samples are available. Serology has been
successfully used to study the dynamics of S. scabiei in-
fections in free-ranging populations of wild carnivores
and ruminants [14–18] but there are no such data on
wild boar. A previous evaluation of an indirect com-
mercial enzyme-linked immunosorbent assay (ELISA)
developed for domestic pigs had revealed a test specifi-
city of 80% when applied on wild boar samples from
populations expected to be free of mange [19]. Never-
theless, it was uncertain whether this value was due to
non-specific reactions, to cross-reactions with other
mites, or to undetected mite infestations. Therefore, a
comparison of seroprevalences obtained for populations
considered as free of mange and those of areas with con-
firmed mange occurrence appeared necessary to better
interpret the data.
The aims of this study were: (1) to assess the extent of
exposure of the wild boar populations to S. scabiei in
Switzerland prior to, and after the detection of mange
cases, in order to determine whether this mite has been
recently introduced into the populations; (2) to estimate
the seroprevalence of S. scabiei in wild boar populations
of several European countries, both from regions with
confirmed clinical cases of mange and from regions
without reported cases, to facilitate the interpretation of
the data obtained for Switzerland. In addition, we pro-
ceeded to a re-estimation of the diagnostic specificity of
the commercial ELISA when applied on sera from free-
ranging wild boar, based on results obtained from areas
without reported cases of mange.
Material and methods
Study areas, animals and samples
We used 2115 archived blood samples from wild
boar from 16 study areas and five European coun-
tries, i.e., Switzerland, France, Italy, Sweden, and
Spain (Additional file 1 and Fig. 1). The countries other
than Switzerland were selected based on the availability of
samples and the existence of a wild boar health monitor-
ing program providing an insight into the mange status of
the local population. Study areas were considered as
epidemiological units because they were either located in
distinct wild boar populations and/or distant from each
other (> 60 km) and/or separated by major geographical
barriers such as lakes and highways.
Target sample sizes were estimated per study area,
using the free software WinEpiscope 2.0 (http://www.wi-
nepi.net/uk/index.htm), with an accepted error of 5%
and level of confidence of 95%. Sample size for preva-
lence estimation in a population of unknown size was
set to 139 for study areas with confirmed or suspected
cases of sarcoptic mange (expected prevalence of 10%)
and to 385 for areas supposed to be free of sarcoptic
mange (expected prevalence of 50%).
In Switzerland, wild boar samples were available from
6 study areas (Table 1 and Fig. 1) and two independent
populations, i.e., the southern population (Ticino) and
the northern population (all other study areas). There
were samples collected prior to (2008–2009; n = 239)
and after (2010–2015; n = 816) the emergence of the
first clinical cases of mange in wild boar. If the number
of archived samples was larger than the target sample
size, samples were arbitrarily selected to obtain, as far as
possible, an even proportion between sexes and among
age classes. In other countries, all samples were collected
after 2010 and all available samples were used. The ob-
tained sample size was below the target for most areas
and the sample composition greatly differed among
areas as concerns sex and age classes (Additional File 1),
which reduced the precision of our prevalence estimates
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and limited the power of comparisons among areas.
Since a major objective was to assess differences in
prevalence between areas with and without reported
cases of mange, areas were categorized according to
their mange status, i.e., N-areas (no reported cases of
mange; 6 areas, n = 1017), S-areas (suspected but uncon-
firmed cases of mange; 2 areas, n = 196), and C-areas
(mange cases confirmed by mite identification; 8 areas,
n = 902), and we used a modelisation approach to test
the effect of the area’s mange status and the potential in-
fluence of individual factors such as sex and age on sero-
logical results (see Statistical Analyses).
Samples were collected post mortem from wild boar
hunted (n = 1955; all countries) or found dead (n = 49;
Switzerland only), and from live animals (n = 111; Spain
only). The age of the wild boar was determined according
to body weight and coat color [20, 21] or based on the
tooth wear of the inferior jaw [22–25]. We harmonized
the dataset using three age classes according to the criteria
of Hebeisen et al. (2008) [21]: 1) piglets (striped, <
6 months old, < 20 kg) and juveniles (reddish, 6–12
months old, between 20 and 40 kg), which were merged
as one juvenile age class for our study; 2) subadults (black
coat, 12–24 months old, > 40 kg and ≤ 60 kg); and 3)
adults (black to silver coat, ≥ 2 years, > 60 kg).
Sampling was performed in the field by game-wardens,
hunters, veterinarians or trained field technicians. In
dead wild boar, blood or blood clots were taken from
the heart, freshly open blood vessels, the retro-orbital
sinus or body cavities. In live wild boar sampling was
performed during capture by venipuncture directly from
the heart prior to euthanasia. After collection, blood
samples were transferred to the respective local labora-
tories, where the serum was separated by centrifugation,
aliquoted and stored at − 20 °C until analysis.
Laboratory analyses
We used the commercial indirect SARCOPTES-ELISA
2001® Pig (AFOSA GmbH, Dahlewitz bei Berlin, Germany),
which uses Sarcoptes mites from pigs as antigen (whole
Fig. 1 Map of western and northern Europe depicting the study areas. Numbers from 1 to 10 represent study areas in France, Sweden, Italy and
Spain as indicated in Table 1. The framed map shows a close-up of Switzerland with the six Swiss study areas in dark green and labelled with the
abbreviations indicated in Table 1
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mite antigen), according to the manufacturer’s instruc-
tions. We previously obtained a sensitivity of 75% and a
specificity of 80% for this test when applied to wild boar
sera, using pig control sera included in the kit [19]. Posi-
tive and negative predictive values of the ELISA obtained
for wild boar sera were 0.56 and 0.94, respectively (C.
Haas, unpublished data).
For the present study, we tested control sera from wild
boar in addition to the pig sera provided in the kit.
Negative wild boar control samples were collected on
captive, healthy juvenile females from the Basel Zoo (Ba-
sel, Switzerland). Positive wild boar control samples were
taken from a free-ranging, mangy juvenile female from
the canton of Solothurn (Switzerland) with confirmed
mite infestation [10]. Optical density (OD) ratios were
calculated using the pig control sera according to the
manufacturer’s instructions. Samples with doubtful re-
sults were re-tested up to six times.
Assuming that the study areas without reported mange
cases are truly mange-free, we re-estimated the specificity
of the ELISA as previously described [19], i.e., we calcu-
lated the proportion of samples with a negative result
within the total number of tested samples expected to be
truly non-infected (samples from N-areas; n = 1017). The
95% confidence interval was calculated according to the
method of Wilson [26].
To compare the OD values obtained with different
plates, a normalized OD value was calculated for each
tested sample by subtracting the blank of the corre-
sponding ELISA-plate from the crude OD value. For
Table 1 Study areas and results of the serosurvey. The total number of tested wild boar samples (n), total number of seropositive
animals (pos), estimated seroprevalences in percent (Prev) and 95% confidence interval (CI) are given for each study area for all
samples (total) and for wild boar ≤2 years old (young age class), together with the p-values of the binomial test comparing the
estimated prevalence of each study area with Uppland (baseline). P-values < 0.05 are highlighted in bold. Note that although
seroprevalence was found to be higher in young than adult wild boar in general, the reverse was observed in Skåne (46 youngs, 22
adults) and Södermanland (3 youngs, 26 adults). Wild boar are free-ranging in all areas but two: The National Domain of Chambord is
fenced with high walls, in this area wild boar are regularly fed by game wardens, and until 2014 medicated food containing ivermectin
was spread on feeding grounds; La Mandria is also delimited by physical boundaries (although occasional outbound and
inbound dispersal movements of wild boar are not excluded)
Country Study area ID
study
area
Mange
statusa
Total samples Young age class only
Prev in % (pos/n) 95% CI p-value Prev in % (pos/n) 95% CI p-value
Switzerland Geneva GE N 2.6 (10 / 389) 1.2–4.7 0.2955 3.3 (9 / 274) 1.5–6.1 0.6096
Midlands SP N 0.1 (1/105) 0.0–5.2 1.0000 1.3 (1 / 77) 0.0–7.0 1.0000
Jura 1 J1 C 12.7 (14 / 110) 7.1–20.4 0.0021 19.7 (14 / 71) 11.2–30.9 0.0150
Jura 2 J2 N 3.4 (3 / 88) 0.7–9.6 0.2696 4.9 (3 / 61) 1.0–13.7 0.4964
Thurgau TG S 1.3 (2 / 150) 0.2–4.7 0.7586 1.7 (2 / 115) 0.2–6.1 1.0000
Ticino TI C 2.8 (6 / 213) 1.0–6.0 0.2823 4.0 (5 / 124) 1.3–9.2 0.5388
France Vosgesb 1 C 14.7 (28 / 191) 10.0–20.5 0.0006 15.0 (21 / 140) 9.5–22.0 0.0378
Chambordc 2 S 17.4 (8 / 46) 7.8–31.4 0.0004 21.1 (4 / 19) 6.1–45.6 0.0276
Sweden Uppland 3 N 0.0 (0 / 82) 0.0–4.4 – 0.0 (0 / 33) 0.0–10.6 –
Södermanland 4 C 10.3 (3 / 29) 2.2–27.4 0.0222 0.0 (0 / 3) 0.0–70.8 NA
Skåne 5 C 10.3 (7 / 68) 4.2–20.1 0.0097 8.7 (4 / 46) 2.4–20.8 0.2231
Italy Aostad 6 C 9.4 (6 / 64) 3.5–19.3 0.0159 23.8 (5 / 21) 8.2–47.2 0.0139
Vercellie 7 C 6.3 (1 / 16) 0.2–30.2 0.3598 8.3 (1 / 12) 0.2–38.5 0.5936
La Mandriaf 8 N 5.6 (10 / 179) 2.7–10.0 0.0665 5.7 (7 / 122) 2.3–11.5 0.3494
Imperiag 9 C 6.2 (13 / 211) 3.3–10.3 0.0473 7.6 (10 / 132) 3.7–13.5 0.2211
Spain Barcelona 10 N 1.2 (2 / 174) 0.1–4.1 0.8306 1.5 (2 / 137) 0.2–5.2 1.0000
aThree different mange status are considered: “non-reported” (N) in absence of known clinical cases, “confirmed” (C) if Sarcoptes scabiei was identified in skin
samples from clinical cases, and “suspected” (S) if wild boar with suspicious skin lesions have occurred but the etiological role of S. scabiei was not confirmed (not
investigated or not detected). In Thurgau, a few wild boar with focally extensive, well demarcated alopecia were documented by phototrapping but not
submitted to veterinary examination. In the National Domain of Chambord, multiple wild boar with suspicious skin lesions were tested for mites in skin scraping
material (light microscopy) or skin samples (histology, polymerase chain reaction) but S. scabiei was never found
bParc Naturel Régional des Vosges du Nord (Vosges Department)
cNational Domain of Chambord (Loir-et-Cher Department)
dAosta Valley Region
eVercelli Province (Piedmont Region)
fParco Regionale La Mandria (Piedmont Region)
gImperia (Liguria Region)
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samples that were tested multiple times, the OD value of
each run was normalized as described above and a sin-
gle, final normalized OD value was obtained for each
sample by calculating the mean of the multiple normal-
ized OD values.
Statistical analyses
Thirty-nine samples which remained doubtful despite
retesting and were distributed among all animal categories
(sex, age, area’s mange status) in seven study areas were
considered as negative in the data analysis. All statistical
analyses were performed using the R software version
3.3.2 (the R Project for statistical computing, available at
https://www.R-project.org/; R Core Team 2016, R: A
language and environment for statistical computing, R
Foundation for Statistical Computing, Vienna, Austria).
Confidence intervals of apparent seroprevalences were
estimated using the binom.test function and were there-
fore automatically computed according to Clopper and
Pearson. We used generalized linear mixed models
(glmm) with a logit link to test the effects of age (juven-
ile, subadult, adult), sex (male, female) and the area’s
mange status (N, S, C) on the probability for a wild boar
to be seropositive (dependent variable). We considered
the serological status of wild boar as a bimodal variable
(0/1): seronegative or doubtful results were encoded 0
and seropositive results were encoded 1. The effect of
the study area (n = 16) was considered as a cluster ran-
dom effect. Glmm models were computed using the
function glmer from the package lme4 [27] and the
dredge function of the package MuMIn (MuMIn, B. K.
2016, multi-model inference, R package version 1.15. 6.
2016.). We started with a “complete model” comprising
the three explanatory variables and tested all simpler
models. Model selection was based on the Akaike's In-
formation Criterion (AIC) and the number of parame-
ters: among the best models, i.e., with the lowest AIC
and delta-AIC less than 2 (models fitting best the
observed data), we retained the most parsimonious
model (with less parameters) [28]. Lastly, parameters of
the best model were estimated using the restricted max-
imum likelihood (REML) method [29] and their signifi-
cance were tested using Wald tests [28].
The Fisher’s exact test (FET) was applied to compare
seroprevalence between age classes (young and adult) in
areas with and without confirmed mange cases (C and N
status). The binomial test for comparison of two propor-
tions (prop.test function) was used to compare the esti-
mated seroprevalences of the different study areas and of
the two sampling periods (before and after the first con-
firmed mange case, in three Swiss study areas for which
older samples were available) with a baseline (a study area
without reported clinical cases of mange and without
seropositive reactions among the tested samples). The
Kruskal-Wallis test and/or Wilcoxon test (with Bonferroni
correction as appropriate) were used to test for signifi-
cant differences among the normalized OD values of
the seropositive and of the seronegative samples from
the different study areas. We expected the average OD
values of both positive and negative samples to be sig-
nificantly lower in N-areas (nonspecific reactions) than
in C-areas (S. scabiei-related reactions). The level of
significance was set at p < 0.05.
Results
The results of the serological survey are presented in
Table 1. Seropositive reactions were observed for sam-
ples from all five countries and from all study areas ex-
cept for Uppland in Sweden, and the highest apparent
seroprevalence was recorded in the National Domain of
Chambord (NDC; 14.4%, 95% CI: 7.4–31.0; Table 1). Re-
garding the considered predictor variables for seroposi-
tivity to S. scabiei, the best model retained the effect of
wild boar age and area’s mange status but not the effect
of sex (Table 2). Corresponding parameters are detailed
in Table 3.
Table 2 Model comparison. List of the generated models and their characteristics. Each table line corresponds to one model. Df =
degree of freedom, logLik = Log-likelihood. Model selection was done according to the Akaike’s Information Criterion (AIC). Models
are ordered according to the AIC, with the best model on the top
Factora df logLik AIC Delta AIC AIC weight
Sex Age Mange status
– + + 6 − 355.205718 722.411435 0 0.63956508
+ + + 7 −354.924564 723.849129 1.43769374 0.31166893
– + – 4 − 360.163851 728.327702 5.91626678 0.03320349
+ + – 5 −359.926631 729.853263 7.44182739 0.01548504
– – + 4 − 366.711672 741.423344 19.0119087 4.76E-05
+ – + 5 −366.397265 742.79453 20.3830952 2.40E-05
– – – 2 − 371.194558 746.389117 23.9776816 3.97E-06
+ – – 3 − 370.926502 747.853004 25.4415691 1.91E-06
aFactor involvement: + stands for inclusion and – for exclusion
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Juveniles were significantly more often seropositive
than adults while no significant difference was found be-
tween juveniles and subadults (Table 3), and these two
age classes were pooled as a “young” age class (≤ 60 kg).
Young wild boar were four times more likely to be sero-
positive than adults (OR young/adult = 4.2, 95% CI: 2.1–
8.3; estimate = 1.4406, standard error = 0.3452, z-value =
4.173, Pr(>|z|) = 3.01e-05 ***). This difference between
the young and adult age classes was observed both in C-
and N-areas (FET, p < 0.001 and p < 0.01, respectively;
Fig. 2). Wild boar from N-areas (no clinical cases re-
ported) showed a significantly lower seroprevalence
(2.6%, 26/1017, 95% CI: 1.7–3.7) than those from C-
areas (confirmed clinical cases; 8.6%, 78/902, 95% CI:
6.9–10.7; OR 4.3, 95% CI: 1.9–9.7).
Tentative comparison among study areas revealed that
all areas with apparent seroprevalence < 1.3% were N-
areas, while areas with seroprevalences ≥ 6.2% were C-
areas except for the NDC (S-area). All areas ≥ 6.2%
showed seroprevalences significantly higher than Upp-
land (N-area, baseline) except Vercelli, for which we had
only a low sample size (6.3%, 95% CI: 3.3–10.3, n = 16).
Seroprevalences from 1.3% to < 6.2% did not signifi-
cantly differ from that in Uppland and corresponded to
a mixture of areas with different mange status: Thurgau
(S-area), Ticino (C-area), Geneva, Jura 2 and La Mandria
(N-areas; Table 1).
Regarding the sampling periods, apparent seropreva-
lences for the Swiss areas Geneva (N-area) and Ticino
(C-area) did not reveal differences from the seropreva-
lence in Uppland in any of the two periods, while the
seroprevalence of Jura 1 (C-area) did significantly differ
from that in Uppland in both periods (Table 4), i.e., we
found no indication that the emergence of clinical cases
in Jura 1 and Ticino was associated with a change in
local seroprevalence.
Regarding the OD values of seropositive samples (n =
114), there was no significant difference between C-areas
and N-areas. Among seronegative wild boar (including
doubtful results; n = 1192), OD values in C-areas were sig-
nificantly higher than values in N-areas (p < 0.05) and the
OD values of wild boar from the NDC (n = 38) differed
from N-areas (p < 0.005) but not from C-areas. Values from
Thurgau (n = 148) did not differ from any group. Further-
more, values of seronegative young wild boar were signifi-
cantly higher than those of seronegative adults (p < 0.001).
Repeated testing of the positive and negative wild boar
control sera always yielded positive and negative results,
respectively. The re-estimated specificity of the test was
96.8% (95% CI: 95.5–97.7) when animals from all pre-
sumably Sarcoptes-free areas were pooled (984 negative
samples out of 1017 tested samples from N-areas; doubt-
ful results excluded); when N-areas were individually
considered, the proportion of negative samples reached
100% for Uppland in Sweden (n = 82).
Discussion
Seropositive wild boar were detected both in areas with
confirmed mite presence (C-areas) and in areas where
wild boar were presumed to have not been exposed to S.
scabiei (N-areas). However, there was a relationship be-
tween the detection of clinical cases and the level of
seroprevalence. Apparent seroprevalences ≥ 6.2% were
all found in C-areas, with the exception of the NDC in
France (suspected unconfirmed cases, S-area), which
displayed the highest prevalence of all study areas. An-
other similarity between C-areas and the NDC was that
seronegative wild boar had a significantly higher mean
OD value than those from N-areas, which may be due to
rising titers in recently exposed wild boar. These obser-
vations together with the repeated observation of
mange-like clinical signs in piglets in the NDC is con-
sistent with an endemic presence of S. scabiei in this
study area despite the unsuccessful mite detection. As
wild boar from this population were occasionally admin-
istered medicated food with ivermectin via feeding
grounds (Table 1), a previous treatment may have elimi-
nated the parasite [30] before the full resolution of the
skin lesions. Alternatively, the clinical examination of
the piglets at capture may have occurred during the
spontaneous healing phase of the disease, after success-
ful elimination of the mite [1, 3, 4], or mite detection
failed due to the poor sensitivity of skin scraping and
PCR in cases with mild lesions, in which mites are few
[31–34].
By contrast, estimated seroprevalences < 6.2% were
associated with an absence of reports of mange cases
(N-areas), except for the Swiss areas Ticino (C-area)
and Thurgau (S-area). In Ticino, mange lesions were
limited to the ears and detected in only two wild
boar [10]. Together with our serological results, this
indicates that S. scabiei can be present at low
Table 3 Parameters of the best model. Model parameters include the estimated logit coefficient (Estimate), the standard error of the
coefficient (Std error), the z score (z-value) and the p-value of the Wald test (Pr(>|z|))
Variable Estimate Std error z-value Pr(>|z|)
Age (adult versus juvenile) −1.42905 0.36330 −3.934 8.37e-05 ***
Age (subadult versus juvenile) 0.02359 0.23062 0.102 0.918534
Mange status (N vs. C) −1.46035 0.41219 −3.543 0.000396 ***
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prevalence in wild boar populations. In line with
this, mean OD values of seropositive samples did
not differ between N- and C-areas. Furthermore,
these data suggest that areas with similar or even
higher seroprevalences than Ticino such as Geneva,
Jura 2 and La Mandria may also be infected despite
the lack of case reports. As for Thurgau, the particu-
larly low prevalence recorded (1.3%, 95% CI 0.2–4.7)
suggests that the observed skin lesions [10] may
have had a different etiology than S. scabiei, such as
Demodex sp. [1, 32, 35]. However, this cannot be
definitely elucidated solely by serology.
Age-related differences
We did not find an effect of the sex on seropositivity, in
accordance with previous observations in other wildlife
species [6, 7, 36, 37] but young wild boar were more
likely to be seropositive than adults. This seropositivity
pattern among age classes was the same in C- and N-
areas (Fig. 2), which does not support the hypothesis
that seropositive wild boar in areas without reported dis-
ease cases were due to unspecific reactions.
Higher seroprevalence in young wild boar suggests a
first exposure to mites early in life. Higher OD values in
young than adult seronegative animals may be due to
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Fig. 2 Histogram of the apparent seroprevalences (in %) according to age classes. The young class (juveniles and subadults, ≤ 60 kg) is
represented in deep blue and the adult class in light blue. The vertical dotted lines over the bars represent the upper limit of the corresponding
95% confidence intervals. Seroprevalence data are given for areas pooled according to their mange status (“confirmed cases”, i.e., Sarcoptes scabiei
was identified in skin samples; and “no reported cases”). The two areas with suspected but unconfirmed cases were excluded from the graph
(National Domain of Chambord in France: likely cases, high apparent seroprevalence, 8 seropositive samples; Thurgau in Switzerland: doubtful
cases, low apparent seroprevalence, 2 seropositive samples)
Table 4 Estimated seroprevalences in the two sampling periods in three study areas in Switzerland. Seroprevalences (Prev) are given in
percent (%) with the number of positive samples (pos) and total number of samples (n) in parenthesis, the 95% confidence interval (CI) and
the p-value of the binomial test applied to compare local seroprevalences with that of Uppland (baseline, see Table 1). This information is
provided both for all samples and for the young age class (≤ 60 kg) only. P-values < 0.05 are highlighted in bold
Study
area
Mange
statusa
Period Total samples Young age class only
Prev in % (pos/n) 95% CI p-value Prev in %, (pos/n) 95% CI p-value
Geneva N 1 3.6 (6/167) 1.3–7.7 0.1944 4.6 (5/108) 1.5–10.5 0.4710
N 2 1.8 (4/222) 0.5–4.6 0.5115 2.4 (4/166) 0.7–6.1 0.8245
Jura 1 N 1 18.2 (2/11) 2.3–51.8 0.0052 25.0 (2/8) 3.2–65.1 0.0423
C 2 12.1 (12/99) 6.4–20.2 0.0031 19.0 (12/63) 10.2–30.9 0.0185
Ticino N 1 5.3 (3/57) 1.1–14.6 0.1318 8.3 (2/24) 1.0–27.0 0.3375
C 2 1.9 (3/156) 0.4–5.5 0.5141 3.0 (3/100) 0.6–8.5 0.7411
aN no reported clinical cases, C confirmed clinical cases (S. scabiei was identified in skin samples)
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rising titers in recently exposed wild boar and decreasing
titers in animals having overcome the infection. Anti-
bodies to S. scabiei persist up to one year after elimin-
ation of the mites [38, 39], i.e., antibodies may not be
detected in adult wild boar unless re-infection has
occurred. In domestic pigs, sheep and rabbits, a second
infection with S. scabiei can be characterized by lower
IgG antibodies and higher IgE antibodies levels than
during the first infection [1, 32, 33, 40, 41]. Thus, adult
wild boar may be less often seropositive than juveniles
and subadults because the ELISA detects IgG antibodies
(instead of IgE) and adult wild boar are more likely to
have been repeatedly exposed to mites than young ani-
mals. These results suggest that the parasite is endemic
in the sampled populations and are consistent with the
perception by field operators that wild boar are mostly
able to cope with S. scabiei infections and not prone to
develop fatal disease [10].
Parasite versus disease occurrence
Our data indicate that S. scabiei may be distributed over
a larger area than inferred when considering only wild
boar with clinical signs of mange. Similarly, antibodies
were detected in healthy chamois (Rupicapra r. rupica-
pra and R. pyrenaica parva) from apparently mange-free
areas [6, 16]. Healthy carriers of S. scabiei have been re-
ported at least in pigs, Spanish ibex (Capra pyrenaica)
and humans [1, 32, 42–44]. Furthermore, it has been
documented that after a peak of sarcoptic mange in a
wild ungulate population, when most sensitive animals
have disappeared, the mite continues to spread among
survivors despite the lack of visible clinical signs [6, 7,
15], and the derived recovering population is remarkably
more resistant to disease [6]. Under such newly estab-
lished endemic conditions, observed seroprevalences are
moderate [16]. Similarly, there has been an increase of
seropositive but apparently healthy red foxes derived
from a population affected by sarcoptic mange for a long
time [45]. Thus, the detection of wild boar seropositive
to S. scabiei in a population without known clinical cases
of mange may not only be due to false-positive reactions
but could also reveal the presence of the parasite in the
population and the existence of a host-parasite equilib-
rium. Since the severity of clinical signs is related to the
ability of the host to control mite infestation [4, 36, 46,
47], animals without lesions are expected to be less in-
fectious than animals with a clinical expression, which
may explain the limited distribution of the parasite in
the population, i.e., the lower seroprevalence.
We have shown that ELISA reactors were similarly
prevalent in different cohorts collected in Switzerland
before and after disease emergence, which is also con-
sistent with an endemic situation. Sample size in
period 1 was limited and results need to be taken
with caution. Nevertheless, the apparent emergence of
clinical cases may have been due to a better detection
thanks to improved monitoring techniques (photo-
trapping) and/or increased disease awareness among
hunters and wildlife professionals in recent years, or
due to a true disease emergence triggered by environ-
mental factors. Host population density, meteoro-
logical conditions and/or food availability are factors
believed to influence the course of infections with S.
scabiei [6, 9, 32].
ELISA performance
The specificity of a diagnostic test in wildlife is particu-
larly difficult to determine as it requires truly non-
infected animals. Unless the individuals were born in
highly controlled captive settings and their health status
closely monitored since birth, exposure to pathogens
cannot be completely ruled out. We previously estimated
the specificity of the SARCOPTES-ELISA 2001® Pig at
80% when applied to wild boar sera, and we interpreted
positive results obtained from free-ranging wild boar
from a supposedly mange-free population (Geneva) as
false positive [19]. Here we obtained a specificity of
96.8% (95% CI 95.5–97.7) when seronegative samples
from all N-areas were considered true negative and we
raise doubts as concerns the mite-free status of Geneva
and some other N-areas. This value of 96.8% is consider-
ably higher than our first estimation and closer to those
generally reported for commercially available or “in-
house” ELISAs [31, 36, 48]. In view of the results from
the present serosurvey, we propose that the specificity is
higher than previously estimated when applied to wild
boar sera. Nevertheless, it would be useful to develop
complementary laboratory tests such as a Western Blot
to confirm the presence of specific S. scabiei antigens
and obtain more accurate serological results in the fu-
ture. An estimation of the sensitivity and specificity of
the ELISA may also be performed with a Bayesian
approach.
Conclusions
This study suggests that S. scabiei is more widely dis-
tributed in free-ranging wild boar populations than
previously assumed and that the parasite has been en-
demic in Switzerland already before the first disease
cases were observed. The awareness of hunters and
wildlife professionals needs to be further promoted to
obtain a better picture of the distribution of clinical
cases and to monitor potential changes in disease oc-
currence. The applied ELISA represents a promising
tool for future surveys.
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Additional file 1: Sample composition and sampling periods for each
study area. Sample size is given as total per study area and according to
sex and age (J = juvenile, S = subadult, A = adult and Un = unknown) of
the sampled wild boar. (DOCX 21 kb)
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